Fishbane S - Search Results

1

CHOIR, CREATE, and anemia treatment in patients with CKD.

Berns JS, Fishbane S. Berns JS, et al. Among authors: fishbane s. Semin Dial. 2007 May-Jun;20(3):277-9. doi: 10.1111/j.1525-139X.2007.00290.x. Semin Dial. 2007. PMID: 17555496 No abstract available.

2

Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?

Berns JS, Fishbane S. Berns JS, et al. Among authors: fishbane s. Semin Dial. 2006 May-Jun;19(3):257-9. doi: 10.1111/j.1525-139X.2006.00165.x. Semin Dial. 2006. PMID: 16689980 No abstract available.

3

Hemoglobin variability in epoetin-treated hemodialysis patients.

Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, Deoreo PB. Berns JS, et al. Among authors: fishbane s. Kidney Int. 2003 Oct;64(4):1514-21. doi: 10.1046/j.1523-1755.2003.00229.x. Kidney Int. 2003. PMID: 12969173 Free article.

4

The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.

Berns JS, Fishbane S, Elzein H, Lynn RI, Deoreo PB, Tharpe DL, Meisels IS. Berns JS, et al. Among authors: fishbane s. Hemodial Int. 2005 Jul;9(3):255-63. doi: 10.1111/j.1492-7535.2005.01139.x. Hemodial Int. 2005. PMID: 16191075

5

How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?

Wyne KL, Fishbane S, Block GA, Warburton K, Berns JS, Neu AM, Warady BA. Wyne KL, et al. Among authors: fishbane s. Semin Dial. 2006 Jan-Feb;19(1):8-24. doi: 10.1111/j.1525-139X.2006.00106.x. Semin Dial. 2006. PMID: 16423174 Review. No abstract available.

6

How can erythropoietin requirements be reduced in dialysis patients?

Kotanko P, Levin NW, Fishbane S, Tarng DC, Berns JS. Kotanko P, et al. Among authors: fishbane s. Semin Dial. 2006 Sep-Oct;19(5):363-72. doi: 10.1111/j.1525-139X.2006.00188.x. Semin Dial. 2006. PMID: 16970733 No abstract available.

7

Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.

Wish JB, Eckardt KU, Kovesdy CP, Fishbane S, Spinowitz BS, Berns JS. Wish JB, et al. Among authors: fishbane s. Am J Kidney Dis. 2021 Nov;78(5):709-718. doi: 10.1053/j.ajkd.2021.06.019. Epub 2021 Jul 28. Am J Kidney Dis. 2021. PMID: 34332007

8

History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.

Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI. Brunelli SM, et al. Among authors: fishbane s. Clin J Am Soc Nephrol. 2008 May;3(3):777-82. doi: 10.2215/CJN.04281007. Epub 2008 Mar 12. Clin J Am Soc Nephrol. 2008. PMID: 18337553 Free PMC article.

9

Evidence and implications of haemoglobin cycling in anaemia management.

Fishbane S, Berns JS. Fishbane S, et al. Nephrol Dial Transplant. 2007 Aug;22(8):2129-32. doi: 10.1093/ndt/gfm384. Epub 2007 Jun 25. Nephrol Dial Transplant. 2007. PMID: 17595177 Review. No abstract available.

10

Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.

Fishbane S, Berns JS. Fishbane S, et al. Kidney Int. 2005 Sep;68(3):1337-43. doi: 10.1111/j.1523-1755.2005.00532.x. Kidney Int. 2005. PMID: 16105069 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page